| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/19/1991 | CA1280364C Polychelating agents for image and spectral enhancement (and spectral shift) |
| 02/17/1991 | CA2023363A1 Use of amide complex compounds |
| 02/13/1991 | EP0412920A2 Diagnostic or therapeutic composition, especially for cancer |
| 02/13/1991 | EP0412104A1 Cold marking of molecules of peptidic or proteinic nature |
| 02/13/1991 | CN1049165A N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe and phenethylamine derivatives |
| 02/13/1991 | CN1011571B Method of preparing for curing tumors |
| 02/12/1991 | US4992555 Certain dipyridylphosphate chelatable compounds capable of forming metal ion chelates |
| 02/12/1991 | US4992554 Used as contrast agent in nuclear magnetic resonance imagery |
| 02/12/1991 | US4992256 Plaque disclosing compositions |
| 02/09/1991 | CA2022755A1 Composition for the diagnosis/treatment of cancer |
| 02/07/1991 | WO1991001305A1 Modified bioluminescent proteins and their use |
| 02/07/1991 | WO1991001296A1 Process for the preparation of 2,4,6-triiodo-5-amino-n-alkylisophthalamic acid and 2,4,6-triiodo-5-amino-isophthalamide compounds |
| 02/07/1991 | WO1991001148A1 Contrast medium composition |
| 02/07/1991 | WO1991001147A1 Particulate contrast media |
| 02/07/1991 | CA2064766A1 Modified bioluminescent proteins and their use |
| 02/07/1991 | CA2062949A1 Particulate constrast media |
| 02/06/1991 | EP0412025A1 Method of entrapping and releasing an active material and micro-capsules obtained thereby |
| 02/06/1991 | EP0410974A1 Nonionic x-ray contrast agents, compositions and methods |
| 02/05/1991 | US4990326 Contacting with labeled monoclonal antibodies |
| 02/05/1991 | CA1279819C Use of cross-linked hydrogel materials as image contrast agents in proton nuclear magnetic resonance tomography and tissue phantom kits containing such materials |
| 02/03/1991 | WO1991001749A1 Method of treatment with medical agents |
| 02/01/1991 | WO1991001759A1 Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
| 02/01/1991 | CA2064567A1 Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | CN1048804A Multipotent powdered cream for apply on electrode and producing technology there-of |
| 01/29/1991 | CA1279564C Method of recording the absorption by organisms, human beings, animals, and plants |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | DE3923797A1 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-fluoro-prostaglandin derivatives, to processes for their preparation and their pharmaceutical use |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | CA2005891A1 Process for the preparation of 2,4,6-triiodo-5-amino-n- alkyl-isophthalamic acid and 2,4,6-triiodo-5-amino- isophthalamide compound |
| 01/23/1991 | EP0409351A1 Contrast medium composition |
| 01/23/1991 | EP0409292A2 Improvements in and relating to magnetic resonance imaging |
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/22/1991 | WO1991001149A1 Contrast media |
| 01/22/1991 | US4986980 Nuclear magnetic resonance and ultrasound imaging |
| 01/22/1991 | US4986979 Imaging tissue sites of inflammation |
| 01/22/1991 | US4986256 Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging |
| 01/22/1991 | CA2059279A1 Contrast medium composition |
| 01/22/1991 | CA2055604A1 Contrast media |
| 01/17/1991 | DE3923798A1 (delta)(pfeil hoch)8(pfeil hoch)-und(delta)(pfeil hoch)9(pfeil hoch)-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung (Delta) (arrow up) 8 (arrow up) -and (delta) (arrow up) 9 (arrow up) -prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/15/1991 | WO1991001303A1 Δ8 and Δ9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 01/15/1991 | WO1991001302A1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 01/15/1991 | US4985550 Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 01/15/1991 | US4985233 A diagnostic agent containing a non-radioactive paramagnetic metal species in a macromolecular carrier |
| 01/15/1991 | US4985166 Magnetizable composite particles based on cross-linked organopolysiloxane, process for preparation thereof and their application in biology |
| 01/15/1991 | US4984573 Method of electron spin resonance enhanced magnetic resonance imaging |
| 01/15/1991 | CA2036386A1 9-fluoroprostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/15/1991 | CA2036383A1 8-and 9-prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/15/1991 | CA1279011C Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000274A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000110A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 01/10/1991 | WO1991000090A1 Oxygenation of blood substitutes |
| 01/09/1991 | EP0407148A2 Angiographic adjuvant |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0406992A2 New non-ionic carboxamide contrast agent |
| 01/09/1991 | EP0406363A1 Method to diagnose amyloidoses specifically and substance therefor. |
| 01/08/1991 | US4983376 Triazamacrocyclic NMR contrast agents and methods for their use |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | CA2035868A1 Hybrid molecules |
| 01/06/1991 | WO1991000743A1 Method for determining oncogenic potential of a chemical compound |
| 01/06/1991 | CA2035464A1 Method for determining oncogenic potential of a chemical compound |
| 01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
| 01/04/1991 | WO1991000364A1 Tcl-5 gene rearrangement involved in t-cell leukemia and melanoma |
| 01/04/1991 | CA2063409A1 Tcl-5 gene rearrangement involved in t-cell leukemia and melanoma |
| 01/02/1991 | EP0405704A2 DTPA-complexes derivatives, pharmaceutical compositions containing them, their use and process for their preparation |
| 01/02/1991 | EP0405537A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| 12/27/1990 | WO1990015807A1 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
| 12/27/1990 | EP0404625A2 Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses |
| 12/27/1990 | EP0403961A2 Magnetic protein conjugates, process to make them and their use |
| 12/27/1990 | EP0403960A2 Magnetic protein conjugates, method to make them and their use |
| 12/27/1990 | EP0403524A1 Preparation of nitruro compounds usable as radio-pharmaceutical products. |
| 12/27/1990 | CA1278242C Aqueous solution for the urodynamic investigation of the urinary bladder |
| 12/25/1990 | US4980502 Paramagnetic chelates |
| 12/25/1990 | US4980148 Methods for enhancing magnetic resonance imaging |
| 12/19/1990 | CA2019217A1 Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 12/18/1990 | US4978763 For magnetic resonance imaging agents synthesis |
| 12/13/1990 | WO1990015158A1 Nucleotide sequences for the amplification of the hiv-2 and siv type retrovirus genome, and their applications in in vitro diagnosis of infections caused by these viruses |
| 12/13/1990 | WO1990014846A1 Percutaneous lymphography |
| 12/12/1990 | EP0401377A1 Iron-containing preparation for use as nmr contrast medium |
| 12/11/1990 | US4977177 Detection and treatment of tumors |
| 12/08/1990 | WO1990015059A1 Photosensitizing diels-alder porphyrin derivatives |
| 12/08/1990 | CA2056431A1 Photosensitizing diels-alder porphyrin derivatives |
| 12/07/1990 | WO1990014840A1 Recombinant alzheimer's amyloid protein |
| 12/03/1990 | WO1990015076A2 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 11/29/1990 | WO1990014435A1 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 11/29/1990 | WO1990010448A3 Covalent conjugates of lipid and oligonucleotide |
| 11/29/1990 | CA2051373A1 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 11/28/1990 | EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY |
| 11/28/1990 | EP0398955A1 Diagnosis of retinoblastoma |
| 11/28/1990 | EP0398935A1 Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents. |
| 11/27/1990 | US4972837 Paramagnetic metal chelate |
| 11/22/1990 | EP0398143A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 11/22/1990 | EP0398024A1 Conjugates for tumor localization and/or tumortherapy |
| 11/22/1990 | EP0397671A1 Use of media containing bubbles in shock wave and ultrasonic therapy |
| 11/22/1990 | CA2017236A1 Antibodies to human mammary cell growth inhibitor and methods of production and use |
| 11/20/1990 | CA1276574C Monoclonal antibodies to activated platelets |